学术探索
学术期刊
新闻热点
数据分析
智能评审

Telithromycin in lower respiratory tract infections

被引：5
作者：
Blasi, F.
Cazzola, M.
Tarsia, P.
Aliberti, S.
Baldessari, C.
Valenti, V.
机构：
[1] Univ Milan, Osped Maggiore, IRCCS, Inst Resp Dis, I-20122 Milan, Italy
[2] Carderelli Hosp, Dept Resp Med, Unit Pneumol & Allergol, Naples, Italy
来源：
FUTURE MICROBIOLOGY | 2006年 / 1卷 / 01期
关键词：
acute exacerbations of chronic bronchitis; asthma; community-acquired pneumonia; telithromycin;
D O I：
10.2217/17460913.1.1.7
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Telithromycin is a ketolide, a semisynthetic derivative of the 14-membered ring macrolide antibiotics, with an expanded spectrum of activity relative to macrolides. Its good tissue pharmacokinetic characteristics allows once-daily administration, and it has been successfully employed in lower respiratory tract infections. Recent data indicate that telithromycin may exert anti-inflammatory/immunomodulatory effects that may be of use in the treatment of both acute and chronic airway diseases. This review examines the role of telithromycin in lower respiratory tract infections, analyzing published data on exacerbations of chronic bronchitis, community-acquired pneumonia and asthma in adults. In addition, pharmacokinetic and pharmacodynamic properties of the drug are considered.
引用
收藏
页码：7 / 16
页数：10
相关论文
共 61 条
  • [1] ACUTE EXACERBATIONS OF ASTHMA IN ADULTS - ROLE OF CHLAMYDIA-PNEUMONIAE INFECTION
    ALLEGRA, L
    BLASI, F
    CENTANNI, S
    COSENTINI, R
    DENTI, F
    RACCANELLI, R
    TARSIA, P
    VALENTI, V
    [J]. EUROPEAN RESPIRATORY JOURNAL, 1994, 7 (12) : 2165 - 2168
  • [2] ANTIBIOTIC-THERAPY IN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
    ANTHONISEN, NR
    MANFREDA, J
    WARREN, CPW
    HERSHFIELD, ES
    HARDING, GKM
    NELSON, NA
    [J]. ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) : 196 - 204
  • [3] Inhibition of secretion of interleukin-1α and tumor necrosis factor alpha by the ketolide antibiotic telithromycin
    Araujo, FG
    Slifer, TL
    Remington, JS
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (10) : 3327 - 3330
  • [4] Telithromycin is as effective as amoxicillin/clavulanate in acute exacerbations of chronic bronchitis
    Aubier, M
    Aldons, PM
    Leak, A
    McKeith, DD
    Leroy, B
    Rangaraju, M
    Bienfait-Beuzon, C
    [J]. RESPIRATORY MEDICINE, 2002, 96 (11) : 862 - 871
  • [5] *AV PHARM, KET TEL TABL
  • [6] Acute exacerbations of chronic bronchitis - An international comparison
    Ball, P
    Make, B
    [J]. CHEST, 1998, 113 (03) : 199S - 204S
  • [7] EPIDEMIOLOGY AND TREATMENT OF CHRONIC-BRONCHITIS AND ITS EXACERBATIONS
    BALL, P
    [J]. CHEST, 1995, 108 (02) : S43 - S52
  • [8] A review of guidelines for antibacterial use in acute exacerbations of chronic bronchitis
    Blasi, Francesco
    Ewig, Santiago
    Torres, Antoni
    Huchon, Gerard
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2006, 19 (05) : 361 - 369
  • [9] Clinical and bacteriologic efficacy of telithromycin in patients with bacteremic community-acquired pneumonia
    Carbon, C
    van Rensburg, D
    Hagberg, L
    Fogarty, C
    Tellier, G
    Rangaraju, M
    Nusrat, R
    [J]. RESPIRATORY MEDICINE, 2006, 100 (04) : 577 - 585
  • [10] Telithromycin 800 mg once daily for seven to ten days is an effective and well-tolerated treatment for community-acquired pneumonia
    Carbon, C
    Moola, S
    Velancsics, I
    Leroy, B
    Rangaraju, M
    Decosta, P
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2003, 9 (07) : 691 - 703
1234567